1. Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial. Issue 7 (13th May 2015) Authors: Ross, S.; Thamer, C.; Cescutti, J.; Meinicke, T.; Woerle, H. J.; Broedl, U. C. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 7(2015:Jul.) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4‐week, randomized, placebo‐controlled trial (EASE‐1). Issue 10 (24th June 2015) Authors: Pieber, T. R.; Famulla, S.; Eilbracht, J.; Cescutti, J.; Soleymanlou, N.; Johansen, O. E.; Woerle, H. J.; Broedl, U. C.; Kaspers, S. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 10(2015:Oct.) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗